Moreover, patients with pure AD who are high in trait–HA may show a positive relationship between DAT availability and the development of pure AD; however, different clinical subgroups and large-scale studies are needed to confirm this possibility. This evidence concerns the gene SLC6A3 and Alzheimer disease.